Proteome Sciences results in big news CJD + Stroke tests

Goatherd

re your comment on the haemorrhagic and ischaemic tests

At the AGM, CJP said at the time that with regrard to the lic. ageements he was negoiating on the basis that the lic. company would get the heart/stroke test and have the rights to the differentiation tests if they helped to fund the development, at the time it appeared that he was not willing to split the tyests between companies. He also said this was the approach he preferred with the BSE/nCJD testing i.e. a company would get the rights to both tests and not one, and the company had to be willing to fund further development of the other tests.

So, I suspect that there is more than an informal agreement with Biosite concerning the testing.

I don't know about anyone else but it seems to me that PRM must have something that other much larger companies want (Aventis and Biosite), so much so they were in one case willing to give up there own proteomics co. and the other to abandon something they were already fairly well advanced in producing themselves for another company's product.

C